Alternatively activated macrophages as therapeutic agents for kidney disease: In vivo stability is a key factor

Kidney International

Volumn 85, Issue 4, 2014, Pages 730-733

  Alagesan, Senthilkumar ^a   Griffin, Matthew D ^a  

^a NATIONAL UNIVERSITY OF IRELAND   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

COLONY STIMULATING FACTOR 1;

ADOPTIVE TRANSFER; ALTERNATIVELY ACTIVATED MACROPHAGE; BONE MARROW CELL; CELL INFILTRATION; CELL MIGRATION; CELL PROLIFERATION; CELL THERAPY; CELLULAR DISTRIBUTION; DISEASE SEVERITY; HUMAN; IN VIVO STUDY; KIDNEY DISEASE; MACROPHAGE ACTIVATION; MONONUCLEAR PHAGOCYTE; NONHUMAN; PRIORITY JOURNAL; REVIEW; THERAPY EFFECT; ANIMAL; IMMUNOLOGY; KIDNEY DISEASES; MACROPHAGE; MALE; SPLEEN; TRANSPLANTATION;

ADOPTIVE TRANSFER; ANIMALS; KIDNEY DISEASES; MACROPHAGES; MALE; SPLEEN;

EID: 84897404519     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/ki.2013.405     Document Type: Note

References (12)

1. Nelson PJ, Rees AJ, Griffin MD et al. The renal mononuclear phagocytic system. J Am Soc Nephrol 2012; 23: 194-203.
2. Sica A, Mantovani A. Macrophage plasticity and polarization: In vivo veritas. J Clin Invest 2012; 122: 787-795.
3. Ricardo SD, van Goor H, Eddy AA. Macrophage diversity in renal injury and repair. J Clin Invest 2008; 118: 3522-3530.
4. Lee S, Huen S, Nishio H et al. Distinct macrophage phenotypes contribute to kidney injury and repair. J Am Soc Nephrol 2011; 22: 317-326.
5. Wang Y, Harris DC. Macrophages in renal disease. J Am Soc Nephrol 2011; 22: 21-27.
6. Griffin MD. Mononuclear phagocyte depletion strategies in models of acute kidney disease: What are they trying to tell us?. Kidney Int 2012; 82: 835-837.
7. Wang Y, Cao Q, Zheng G et al. By homing to the kidney, activated macrophages potently exacerbate renal injury. Am J Pathol 2008; 172: 1491-1499.
8. Wang Y, Wang YP, Zheng G et al. Ex vivo programmed macrophages ameliorate experimental chronic inflammatory renal disease. Kidney Int 2007; 72: 290-299.
9. Cao Q, Wang Y, Zheng D et al. Failed renoprotection by alternatively activated bone marrow macrophages is due to a proliferation-dependent phenotype switch in vivo. Kidney Int 2014; 85: 794-806.
10. Murray PJ, Wynn TA. Protective and pathogenic functions of macrophage subsets. Nat Rev Immunol 2011; 11: 723-737.
11. Hutchinson JA, Riquelme P, Sawitzki B et al. Cutting Edge: Immunological consequences and trafficking of human regulatory macrophages administered to renal transplant recipients. J Immunol 2011; 187: 2072-2078.
12. Powell RJ, Marston WA, Berceli SA et al. Cellular therapy with Ixmyelocel-T to treat critical limb ischemia: The randomized, double-blind, placebo-controlled RESTORECLI trial. Mol Ther 2012; 20: 1280-1286.